P
Peter Deibert
Researcher at University of Freiburg
Publications - 83
Citations - 4351
Peter Deibert is an academic researcher from University of Freiburg. The author has contributed to research in topics: Portal hypertension & Cirrhosis. The author has an hindex of 28, co-authored 77 publications receiving 4066 citations. Previous affiliations of Peter Deibert include University Medical Center Freiburg.
Papers
More filters
Journal ArticleDOI
Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection.
Riccardo Lencioni,Hans Peter Allgaier,Dania Cioni,M. Olschewski,Peter Deibert,Laura Crocetti,Holger Frings,Joerg Laubenberger,Ina Zuber,Hubert E. Blum,Carlo Bartolozzi +10 more
TL;DR: RF ablation is superior to PEI with respect to local recurrence-free survival rates with multivariate analysis and prognostic value of treatment techniques was assessed with univariate and multivariate Cox proportional hazards regression models.
Journal ArticleDOI
A Comparison of Paracentesis and Transjugular Intrahepatic Portosystemic Shunting in Patients with Ascites
Martin Rössle,A. Ochs,Veit Gülberg,V. Siegerstetter,J. Holl,Peter Deibert,Manfred Olschewski,Maximilian F. Reiser,Alexander L. Gerbes +8 more
TL;DR: In comparison with large-volume paracentesis, the creation of a transjugular intrahepatic portosystemic shunt can improve the chance of survival without liver transplantation in patients with refractory or recurrent ascites.
Journal ArticleDOI
The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites.
A. Ochs,Martin Rössle,K. Haag,Karl-Heinz Hauenstein,Peter Deibert,V. Siegerstetter,Martin Huonker,Mathias Langer,Hubert E. Blum +8 more
TL;DR: The stent shunt was successfully placed in all patients and reduced the pressure gradient between the portal vein and the inferior vena cava by an average of 63 percent.
Journal ArticleDOI
Randomised trial of transjugular-intrahepatic-portosystemic shunt versus endoscopy plus propranolol for prevention of variceal rebleeding
Martin Rössle,Peter Deibert,K. Haag,A. Ochs,M Olchewski,V. Siegerstetter,K-H Hauenstein,R Geiger,C Stiepak,W Keller,Hubert E. Blum +10 more
TL;DR: It is suggested that the transjugular shunt is more effective than endoscopic treatment in prevention of variceal rebleeding but has a considerable risk of hepatic encephalopathy.
Journal ArticleDOI
Treatment of refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt: long-term results in 40 patients.
TL;DR: TIPS is effective for hydrothorax refractory to diuretic treatment and other standard interventions to bridge the time to transplantation and showed a significant inverse correlation with age over 60 years.